Literature DB >> 8169413

The role of swarm cell differentiation and multicellular migration in the uropathogenicity of Proteus mirabilis.

C Allison1, L Emödy, N Coleman, C Hughes.   

Abstract

The uropathogenic bacterium Proteus mirabilis displays a form of multicellular behavior called swarming, in which typical vegetative rods differentiate into long hyperflagellate swarm cells that undergo rapid and coordinated population migration across surfaces. Such behavior might inherently assist ascending colonization of the urinary tract, and it has also been shown that swarming differentiation in vitro is central to the expression of conventional virulence factors. This study provides support for a role of swarming in vivo. Mortality rates of mice inoculated intravenously with 2.5 x 10(8) vegetative cells were lower than rates for those inoculated with wild type strains in the case of motile transposon mutants either completely unable to swarm (< 1%) or able to undergo only aberrant swarming migration (< 40%, P < .001). Histologic analysis of renal tissues from mice infected by wild type Proteus strains showed that long differentiated cells were the major cell type, whereas the extracellular inflammatory exudate contained primarily short vegetative cells. Following intravesical (bladder) inoculation with 2.0 x 10(7) vegetative cells, kidney infection was not established by any of the three motile swarm-defective mutants; indeed, the nonswarming mutant was not retained in the bladder. In contrast, the wild type strain and a normally swarming but nonhemolytic mutant achieved a high incidence of ascending infection to the kidney.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8169413     DOI: 10.1093/infdis/169.5.1155

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  48 in total

Review 1.  Surface motility of serratia liquefaciens MG1.

Authors:  L Eberl; S Molin; M Givskov
Journal:  J Bacteriol       Date:  1999-03       Impact factor: 3.490

2.  Loss of regulatory protein RfaH attenuates virulence of uropathogenic Escherichia coli.

Authors:  Gábor Nagy; Ulrich Dobrindt; György Schneider; A Salam Khan; Jörg Hacker; Levente Emödy
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

3.  Salmonella typhimurium flhE, a conserved flagellar regulon gene required for swarming.

Authors:  Graham P Stafford; Colin Hughes
Journal:  Microbiology       Date:  2007-02       Impact factor: 2.777

Review 4.  Proteus spp. as Putative Gastrointestinal Pathogens.

Authors:  Amy L Hamilton; Michael A Kamm; Siew C Ng; Mark Morrison
Journal:  Clin Microbiol Rev       Date:  2018-06-13       Impact factor: 26.132

Review 5.  Pathogenesis of Proteus mirabilis Infection.

Authors:  Chelsie E Armbruster; Harry L T Mobley; Melanie M Pearson
Journal:  EcoSal Plus       Date:  2018-02

6.  Variants of smooth Salmonella enterica serovar Enteritidis that grow to higher cell density than the wild type are more virulent.

Authors:  J Guard-Petter
Journal:  Appl Environ Microbiol       Date:  1998-06       Impact factor: 4.792

7.  Zinc uptake contributes to motility and provides a competitive advantage to Proteus mirabilis during experimental urinary tract infection.

Authors:  Greta R Nielubowicz; Sara N Smith; Harry L T Mobley
Journal:  Infect Immun       Date:  2010-04-12       Impact factor: 3.441

8.  Molecular analysis of a metalloprotease from Proteus mirabilis.

Authors:  C Wassif; D Cheek; R Belas
Journal:  J Bacteriol       Date:  1995-10       Impact factor: 3.490

Review 9.  Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Authors:  S M Jacobsen; D J Stickler; H L T Mobley; M E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

10.  Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold.

Authors:  Laurel S Burall; Janette M Harro; Xin Li; C Virginia Lockatell; Stephanie D Himpsl; J Richard Hebel; David E Johnson; Harry L T Mobley
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.